Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 17, 2026Genome MedicineOpen Access

Genomic characterization of circulating respiratory syncytial virus strains in Lombardy before and after the introduction of nirsevimab prophylaxis

View Full Paper
Ask AI
Bookmark
Share

Authors

SRSara Uceda RenteriaCGCristina GalliGFGuglielmo Ferrari

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Renteria et al. (2026) studied this question.

synapsesocial.com/papers/6aabb7865f706d05830e697bhttps://doi.org/10.1186/s13073-026-01768-x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Genomic evolution of human respiratory syncytial virus during a decade (2013–2023): bridging the path to monoclonal antibody surveillance2024 · 17 citations
  2. 2Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France2026 · 6 citations
  3. 3185. Nirsevimab Binding Site Conservation in RSV F Protein between 2019 and 2024: Analysis of Sequencing Data from the US OUTSMART-RSV Surveillance Study and Public Databases2026
  4. 4Detection of nirsevimab-resistant RSV-B variants in children carrying the F:N201T substitution through genomic surveillance, Spain, 2025/26 season2026
  5. 5B17-04 RSV Immunoprophylaxis in Infants and Breakthrough Infection: Clinical Impact and Virological Features2026